At the congress 'Anonymization for Secure Data Usage', leading branches heads came together in Lübeck from April 16th to 17th, 2024, to present and discuss the latest findings and innovative approaches to data anonymization.

Radiology clinics and practices in Switzerland can now obtain the AI-based software "Prostate.Carcinoma.ai" from the Hamburg-based e-health company FUSE-AI centrally through T-Systems, which assists radiologists in analyzing prostate MR images.

FUSE-AI was represented at 4YFN in mid-February in Barcelona. 4YFN is all about promoting start-ups, giving them a stage to shine, connecting with investors, showcasing their groundbreaking ideas and providing plenty of opportunities for intensive networking. All this took place in the lively atmosphere of the Mobile World Congress (MWC).

In the field of machine control using Large Language Models (LLMs), overcoming technical obstacles requires innovative solutions on various levels. Researchers and developers are tackling each challenge with determination, devising strategies to enhance the capabilities of LLMs in effectively controlling machines.

Our AI-based software Prostate.Carcinoma.ai supports radiologists in the detection and segmentation of the prostate gland, their zones and suspicious lesions on MRI images. Mint Medical was involved in our software development from the very beginning with advice and their experiences as platform developer for radiologists.

Arab Health 2024 is the largest trade fair and congress for medicine and healthcare in the Middle East that ran from January 29 - February 1 this year.

We are excited to announce a pioneering collaboration between the Helmut-Schmidt-University/University of the Federal Armed Forces (HSU/UniBw H) and FUSE-AI, a partnership that will be used to transform the field of robotics.

From January 29 to February 1, FUSE-AI will be present in Za'abeel Hall, booth Z6, F46 and is looking forward to introducing the functionality of Prostate.Carcinoma.ai, our AI-based software to facilitate MRI analysis for radiologists. In December, our software was certified according to (EU) MDR for medical devices class IIa.

On December 15, we were very happy to receive the announcement from our Notified Body that we have fulfilled all the requirements of EU MDR IIa.

FUSE-AI was nominated as one of the 12 finalists for the Startup-Competition, which was pre-selected by Medica from a pool of 260 startups. On November 14, 2023, Matthias Steffen presented Prostate.Carcinoma.ai in light of the global demand for AI-based diagnostic assistance systems and our upcoming market entry.